BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31715012)

  • 21. Stereotactic radiosurgery for pituitary adenoma invading the cavernous sinus.
    Shin M; Kurita H; Sasaki T; Tago M; Morita A; Ueki K; Kirino T
    J Neurosurg; 2000 Dec; 93 Suppl 3():2-5. PubMed ID: 11143249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Predictive value of the Knosp classification in grading the surgical resection of invasive pituitary macroadenomas. A prospective study of 23 cases].
    Enseñat J; Ortega A; Topcewski T; Vilalta J; Obiols G; Mesa J; Sahuquillo J
    Neurocirugia (Astur); 2006 Dec; 17(6):519-26. PubMed ID: 17242839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of intracavernous extensions of pituitary adenomas.
    MacKay A; Hosobuchi Y
    Surg Neurol; 1978 Dec; 10(6):377-83. PubMed ID: 741360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Technical aspects and surgical strategy for removal of corticotroph pituitary adenoma].
    Perrin G; Stevenaert A; Jouanneau E
    Neurochirurgie; 2002 May; 48(2-3 Pt 2):186-214. PubMed ID: 12058125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative assessment of the results of different surgical treatments in patients with pituitary adenomas infiltrating the cavernous sinus].
    Kadashev BA; Kutin MA; Kalinin PL; Trunin IuK; Alekseev SN; Shkarubo AN
    Zh Vopr Neirokhir Im N N Burdenko; 2004; (3):14-7; discussion 17. PubMed ID: 15490633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endoscopic endonasal transsphenoidal approach for pituitary adenomas invading the cavernous sinus.
    Ceylan S; Koc K; Anik I
    J Neurosurg; 2010 Jan; 112(1):99-107. PubMed ID: 19480546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent results of secondary transnasal surgery for residual or recurring acromegaly.
    Abe T; Lüdecke DK
    Neurosurgery; 1998 May; 42(5):1013-21; discussion 1021-2. PubMed ID: 9588545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repeated transsphenoidal surgery to treat recurrent or residual pituitary adenoma.
    Benveniste RJ; King WA; Walsh J; Lee JS; Delman BN; Post KD
    J Neurosurg; 2005 Jun; 102(6):1004-12. PubMed ID: 16028758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Basis of persistent and recurrent Cushing disease: an analysis of findings at repeated pituitary surgery.
    Dickerman RD; Oldfield EH
    J Neurosurg; 2002 Dec; 97(6):1343-9. PubMed ID: 12507132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medial compartment of the cavernous sinus.
    Goel A; Nadkarni T
    J Neurosurg; 1995 Oct; 83(4):763-4. PubMed ID: 7674037
    [No Abstract]   [Full Text] [Related]  

  • 31. Intraoperative high-field MRI for transsphenoidal reoperations of nonfunctioning pituitary adenoma.
    Berkmann S; Schlaffer S; Nimsky C; Fahlbusch R; Buchfelder M
    J Neurosurg; 2014 Nov; 121(5):1166-75. PubMed ID: 25127413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Surgery of pituitary adenoma].
    Derome PJ; Visot A
    Rev Prat; 1996 Jun; 46(12):1515-9. PubMed ID: 8881167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Objective criteria for successful transsphenoidal removal of suprasellar nonfunctioning pituitary adenomas. A prospective study.
    Honegger J; Ernemann U; Psaras T; Will B
    Acta Neurochir (Wien); 2007 Jan; 149(1):21-9; discussion 29. PubMed ID: 17086476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery.
    Meij BP; Lopes MB; Ellegala DB; Alden TD; Laws ER
    J Neurosurg; 2002 Feb; 96(2):195-208. PubMed ID: 11838791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Value of transcavernous surgery in the treatment of pituitary adenomas.
    Lüdecke DK
    Eur J Endocrinol; 1995 Aug; 133(2):147-8. PubMed ID: 7655637
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pretemporal transcavernous approach tailored surgery of cavernous sinus tumors: a consecutive series of 31 cases report].
    Su J; Yuan X; Zhao Z; Wang X; Wang J; Xiao K; Li H; Zhang C; Yuan J; Liu D; Liu Q
    Zhonghua Wai Ke Za Zhi; 2016 May; 54(5):367-71. PubMed ID: 27143207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endoscopic Endonasal Surgery for Tumors of the Cavernous Sinus: A Series of 234 Patients.
    Koutourousiou M; Vaz Guimaraes Filho F; Fernandez-Miranda JC; Wang EW; Stefko ST; Snyderman CH; Gardner PA
    World Neurosurg; 2017 Jul; 103():713-732. PubMed ID: 28450229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical management of giant pituitary tumours--a review of 30 cases.
    Goel A; Nadkarni T
    Acta Neurochir (Wien); 1996; 138(9):1042-9. PubMed ID: 8911540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term surgical outcome in 16 patients with thyrotropin pituitary adenoma.
    Sanno N; Teramoto A; Osamura RY
    J Neurosurg; 2000 Aug; 93(2):194-200. PubMed ID: 10930003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cavernous Sinus Invasion in Pituitary Adenomas: Systematic Review and Pooled Data Meta-Analysis of Radiologic Criteria and Comparison of Endoscopic and Microscopic Surgery.
    Dhandapani S; Singh H; Negm HM; Cohen S; Anand VK; Schwartz TH
    World Neurosurg; 2016 Dec; 96():36-46. PubMed ID: 27591098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.